Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Skeletal muscle atrophy, referred to as sarcopenia, is often observed in chronic kidney disease (CKD) patients, especially in patients who are undergoing hemodialysis. The purpose of this study was to determine whether uremic toxins are involved in CKD-related skeletal muscle atrophy. Among six protein-bound uremic toxins, indole containing compounds, indoxyl sulfate (IS) significantly inhibited proliferation and myotube formation in C2C12 myoblast cells. IS increased the factors related to skeletal muscle breakdown, such as reactive oxygen species (ROS) and inflammatory cytokines (TNF-α, IL-6 and TGF-β1) in C2C12 cells. IS also enhanced the production of muscle atrophy-related genes, myostatin and atrogin-1. These effects induced by IS were suppressed in the presence of an antioxidant or inhibitors of the organic anion transporter and aryl hydrocarbon receptor. The administered IS was distributed to skeletal muscle and induced superoxide production in half-nephrectomized (1/2 Nx) mice. The chronic administration of IS significantly reduced the body weights accompanied by skeletal muscle weight loss. Similar to the in vitro data, IS induced the expression of myostatin and atrogin-1 in addition to increasing the production of inflammatory cytokines by enhancing oxidative stress in skeletal muscle. These data suggest that IS has the potential to accelerate skeletal muscle atrophy by inducing oxidative stress-mediated myostatin and atrogin-1 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Namely, the circulating levels of microbiota-derived indoxyl sulfate are positively associated with the expression of myostatin and atrogin-1 [29], representing two of the main negative regulators of skeletal muscle mass [30].”
From Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia (2019) · cites this paper as [29]
Experimental — accuracy not yet measuredIn the citing paper
“Gut microbiota dysregulation may promote the onset of sarcopenia and obesity through myostatin and atrogin-1 expression [20] and dysfunctional signaling between the enteric nervous system and the brain, respectively [21], imposing a negative impact on muscle mass and appetite.”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [20]
In the citing paper
“the tryptophan derivative indoxyl sulfate, which is similarly shown to increase with age [60], is reported to induce inflammatory cytokine expression (IL-6 and TNF-α) and markers of muscle atrophy (myostatin and atrogin-1) similar to that of LPS in cultured myocytes [61].”
From Gut Microbiota Contribute to Age-Related Changes in Skeletal Muscle Size, Composition, and Function: Biological Basis for a Gut-Muscle Axis (2018) · cites this paper as [61]
In the citing paper
“in vivo administration of indoxyl sulfate is shown to increase atrogene expression in conjunction with decreased muscle mass in mice [61].”
From Gut Microbiota Contribute to Age-Related Changes in Skeletal Muscle Size, Composition, and Function: Biological Basis for a Gut-Muscle Axis (2018) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Cellular and molecular mechanisms of muscle atrophy
Bonaldo, P., & Sandri, M. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010389 · Cited by 1,284
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Bodine, S. C., & Baehr, L. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00204.2014 · Cited by 1,113
Mechanisms of muscle wasting in chronic kidney disease
Wang, X. H., & Mitch, W. E. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.112 · Cited by 616
Dioxin receptor is a ligand-dependent E3 ubiquitin ligase
Ohtake, F., Baba, A., Takada, I., Okada, M., Iwasaki, K., Miki, H., Takahashi, S., Kouzmenko, A., Nohara, K., Chiba, T., et al. (2007) · Nature · doi:10.1038/nature05683 · Cited by 584
Smad2 and 3 transcription factors control muscle mass in adulthood
Sartori, R., Milan, G., Patron, M., Mammucari, C., Blaauw, B., Abraham, R., & Sandri, M. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00104.2009 · Cited by 517
McFarlane, C., Plummer, E., Thomas, M., Hennebry, A., Ashby, M., Ling, N., Smith, H., Sharma, M., & Kambadur, R. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20757 · Cited by 480
Conditional Activation of Akt in Adult Skeletal Muscle Induces Rapid Hypertrophy
Lai, K.-M. V., Gonzalez, M., Poueymirou, W. T., Kline, W. O., Na, E., Zlotchenko, E., Stitt, T. N., Economides, A. N., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9295-9304.2004 · Cited by 442
Oliver, M. H., Harrison, N. K., Bishop, J. E., Cole, P. J., & Laurent, G. J. (1989) · Journal of Cell Science · doi:10.1242/jcs.92.3.513 · Cited by 401
Cited by
Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia
Ticinesi, A., Nouvenne, A., Cerundolo, N., Catania, P., Prati, B., Tana, C., & Meschi, T. (2019) · Nutrients · doi:10.3390/nu11071633 · Cited by 418
“Namely, the circulating levels of microbiota-derived indoxyl sulfate are positively associated with the expression of myostatin and atrogin-1 [29], representing two of the main negative regulators of skeletal muscle mass [30].”
BackgroundGrosicki, G. J., Fielding, R. A., & Lustgarten, M. S. (2018) · Calcified Tissue International · doi:10.1007/s00223-017-0345-5 · Cited by 388
“Furthermore, in vivo administration of indoxyl sulfate is shown to increase atrogene expression in conjunction with decreased muscle mass in mice [61].”
BackgroundUnderstanding the gut microbiota and sarcopenia: a systematic review
Liu, C., Cheung, W., Li, J., Chow, S. K., Yu, J., Wong, S. H., Ip, M., Sung, J. J. Y., & Wong, R. M. Y. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12784 · Cited by 363
“Figure 2 The molecular signalling pathways of gut microbiota and skeletal muscle: the noxious bacterial metabolites (indoxyl sulfate and LPS) and absence of gut microbiota (black) induced muscle atrophy.(39,94,95,97,99,100,102) Indoxyl sulfate and LPS caused muscle atrophy and inflammation by activating the PI3K/ AKT,…”
BackgroundSarcopenia and Muscle Aging: A Brief Overview
Dao, T., Green, A. E., Kim, Y. A., Bae, S.-J., Ha, K.-T., Gariani, K., Lee, M.-R., Menzies, K. J., & Ryu, D. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.405 · Cited by 228
Lipotoxicity in Kidney, Heart, and Skeletal Muscle Dysfunction
Nishi, H., Higashihara, T., & Inagi, R. (2019) · Nutrients · doi:10.3390/nu11071664 · Cited by 172
Enoki, Y., Watanabe, H., Arake, R., Fujimura, R., Ishiodori, K., Imafuku, T., Nishida, K., Sugimoto, R., Nagao, S., Miyamura, S., et al. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12202 · Cited by 164
Self-citationJiang, H., Chen, C., & Gao, J. (2022) · Nutrients · doi:10.3390/nu15010151 · Cited by 160
Chronic kidney disease-induced muscle atrophy: Molecular mechanisms and promising therapies
Wang, K., Liu, Q., Tang, M., Qi, G., Qiu, C., Huang, Y. H., Yu, W., Wang, W., Sun, H., Ni, X., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115407 · Cited by 160
Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions
Watanabe, H., Enoki, Y., & Maruyama, T. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00513 · Cited by 134
Self-citationKynurenine signaling through the aryl hydrocarbon receptor: Implications for aging and healthspan
Kaiser, H., Parker, E. J., & Hamrick, M. W. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110797 · Cited by 112
Gut microbiota as a promising therapeutic target for age-related sarcopenia
Zhang, T., Cheng, J.-K., & Hu, Y. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101739 · Cited by 112
Myostatin and muscle atrophy during chronic kidney disease
Bataille, S., Chauveau, P., Fouque, D. P., Aparicio, M., & Koppe, L. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa129 · Cited by 103
Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins
de Brito, J. S., Borges, N. A., Esgalhado, M., Magliano, D. C., Soulage, C. O., & Mafra, D. (2017) · The Nephron journals/Nephron journals · doi:10.1159/000476074 · Cited by 100
Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective
Prokopidis, K., Cervo, M. M., Gandham, A., & Scott, D. (2020) · Nutrients · doi:10.3390/nu12082285 · Cited by 99
“Gut microbiota dysregulation may promote the onset of sarcopenia and obesity through myostatin and atrogin-1 expression [20] and dysfunctional signaling between the enteric nervous system and the brain, respectively [21], imposing a negative impact on muscle mass and appetite.”
BackgroundThome, T., Salyers, Z. R., Kumar, R. A., Hahn, D., Berru, F. N., Ferreira, L. F., Scali, S. T., & RYAN, T. E. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00098.2019 · Cited by 101
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective
Salvioli, S., Basile, M. S., Bencivenga, L., Carrino, S., Conte, M., Damanti, S., LORENZO, R. D., Fiorenzato, E., Gialluisi, A., Ingannato, A., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102044 · Cited by 98
Huang, Z., Fang, Q., Ma, W., Zhang, Q., Qiu, J., Gu, X., Yang, H., & Sun, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00997 · Cited by 96
Gut-muscle crosstalk. A perspective on influence of microbes on muscle function
Chew, W., Lim, Y. P., Lim, W. S., Chambers, E. S., Frost, G. S., Wong, S. H., & Ali, Y. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1065365 · Cited by 94
Mori, K. (2021) · Nutrients · doi:10.3390/nu13051538 · Cited by 92
Kim, K., Anderson, E., Thome, T., Lu, G., Salyers, Z. R., Cort, T. A., O’Malley, K. A., Scali, S. T., & RYAN, T. E. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00117.2021 · Cited by 91
Thome, T., Kumar, R. A., Burke, S., Khattri, R. B., Salyers, Z. R., Kelley, R. C., Coleman, M. D., Christou, D. D., Hepple, R. T., Scali, S. T., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.139826 · Cited by 91
Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease
Jazani, N. H., Savoj, J., Lustgarten, M. S., Lau, W. L., & Vaziri, N. D. (2019) · Diseases · doi:10.3390/diseases7010021 · Cited by 90
Sato, E., Saigusa, D., Mishima, E., Uchida, T., Miura, D., Morikawa, T., Kisu, K., Sekimoto, A., Saito, R., Oe, Y., et al. (2017) · Toxins · doi:10.3390/toxins10010019 · Cited by 85
Myostatin: Basic biology to clinical application
Esposito, P. B., Picciotto, D., Battaglia, Y., Costigliolo, F., Viazzi, F. C., & Verzola, D. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.09.006 · Cited by 83
Iron Metabolism of the Skeletal Muscle and Neurodegeneration
Hałoń, M., Borkowska, A., Herman-Antosiewicz, A., & Antosiewicz, J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00165 · Cited by 82
Bisphenol A is an exogenous toxin that promotes mitochondrial injury and death in tubular cells
Bosch‐Panadero, E., Mas, S., Civantos, E., Abaigar, P., Camarero, V., Priego, A. R., Ortíz, A., Egido, J., & González‐Parra, E. (2017) · Environmental Toxicology · doi:10.1002/tox.22519 · Cited by 81
Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease
Lu, C., Zheng, C., Lu, K., Liao, M.-T., Wu, K., & Ma, M. (2021) · Antioxidants · doi:10.3390/antiox10060936 · Cited by 79
Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach
Nishi, H., Takemura, K., Higashihara, T., & Inagi, R. (2020) · Nutrients · doi:10.3390/nu12061814 · Cited by 67
Sárközy, M., Kovács, Z. Z. A., Kovács, M. G., Gáspár, R., Szűcs, G., & László, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01648 · Cited by 67
Indoxyl Sulfate Contributes to mTORC1-Induced Renal Fibrosis via The OAT/NADPH Oxidase/ROS Pathway
Nakano, T., Watanabe, H., Imafuku, T., Tokumaru, K., Fujita, I., Arimura, N., Maeda, H., Tanaka, M., Matsushita, K., Fukagawa, M., et al. (2021) · Toxins · doi:10.3390/toxins13120909 · Cited by 66
Self-citationWang, Y., Zhang, J., Wang, J., Zhang, Y., Sun, J., Gong, J., Yao, X., & Sun, H. (2026) · Pharmaceuticals · doi:10.3390/ph19060868 · Cited by 63
Nishiyama, K., Aono, K., Fujimoto, Y., Kuwamura, M., Okada, T., Tokumoto, H., Izawa, T., Okano, R., Nakajima, H., Takeuchi, T., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27408 · Cited by 61
Bakinowska, E., Olejnik-Wojciechowska, J., Kiełbowski, K., Skoryk, A., & Pawlik, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158474 · Cited by 56
Delanaye, P., Bataille, S., Quinonez, K., Buckinx, F., Warling, X., Krzesinski, J.-M., Pottel, H., Burtey, S., Bruyère, O., & Cavalier, E. (2019) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2018.11.010 · Cited by 56
Kato, H., Watanabe, H., Imafuku, T., Arimura, N., Fujita, I., Noguchi, I., Tanaka, S., Nakano, T., Tokumaru, K., Enoki, Y., et al. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12786 · Cited by 56
Self-citationSummers, S., & Quimby, J. M. (2024) · The Veterinary Journal · doi:10.1016/j.tvjl.2024.106181 · Cited by 52
Indoxyl sulfate induces myotube atrophy by ROS-ERK and JNK-MAFbx cascades
Changchien, C., Lin, Y., Cheng, Y., Chang, H., Peng, Y., & Chen, Y. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.02.023 · Cited by 51
He, W., Luo, Y., Liu, J.-P., Sun, N., Guo, D., Cui, L.-L., Zheng, P.-P., Yao, S.-M., Yang, J.-F., & Wang, H. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s270887 · Cited by 50
Heitman, K., Alexander, M. S., & Faul, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105117 · Cited by 50
Zhang, Z., Guo, Q., Yang, Z., Sun, Y., Jiang, S., He, Y., Li, J., & Zhang, J. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115265 · Cited by 51
Tsai, C.-J., Wang, P.-C., Hsiung, T., Fan, Y.-H., Wu, J.-T., Kan, W., & Shiao, C. (2025) · Biomedicines · doi:10.3390/biomedicines13020352 · Cited by 50
Milanesi, S., Garibaldi, S., Saio, M., Ghigliotti, G., Picciotto, D., Ameri, P., Garibotto, G., Barisione, C., & Verzola, D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2050183 · Cited by 49
Cappellari, G. G., Semolic, A., Ruozi, G., Vinci, P., Guarnieri, G., Bortolotti, F., Barbetta, D., Zanetti, M., Giacca, M., & Barazzoni, R. (2017) · The FASEB Journal · doi:10.1096/fj.201700126r · Cited by 48
Jheng, J., Chen, Y., Ao, U. I., Chan, D., Huang, J., Hung, K., Tarng, D., & Chiang, C. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12288 · Cited by 47
Regulatory Role of MicroRNAs in Muscle Atrophy during Exercise Intervention
Zhang, S., & Chen, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020405 · Cited by 46
Prevotella copri alleviates sarcopenia via attenuating muscle mass loss and function decline
Liu, X., Wu, J., Tang, J., Xu, Z., Zhou, B., Liu, Y., Hu, F., Zhang, G., Cheng, R., Xia, X., et al. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13313 · Cited by 45
Intake of medium-chain fatty acids induces myocardial oxidative stress and atrophy
Miyagawa, Y., Mori, T., Goto, K., Kawahara, I., Fujiwara‐Tani, R., Kishi, S., Sasaki, T., Fujii, K., Ohmori, H., & Kuniyasu, H. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0908-0 · Cited by 45
Berru, F. N., Gray, S. E., Thome, T., Kumar, R. A., Salyers, Z. R., Coleman, M. D., Le, D., O’Malley, K. A., Ferreira, L. F., Berceli, S. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52107-7 · Cited by 45
Augmented temperature fluctuation aggravates muscular atrophy through the gut microbiota
Liu, Y., Guo, Y., Liu, Z., Xu, F., Zhou, R., He, Y., Zhou, H., Peng, H., & Huang, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-39171-4 · Cited by 44
Chung, L.-H., Liu, S., Huang, S., Salter, D. M., Lee, H., & Hsu, Y. (2020) · Aging · doi:10.18632/aging.103896 · Cited by 43
Tissue-Specific 1H-NMR Metabolomic Profiling in Mice with Adenine-Induced Chronic Kidney Disease
Khattri, R. B., Thome, T., & RYAN, T. E. (2021) · Metabolites · doi:10.3390/metabo11010045 · Cited by 43
Role of the Gut Microbiome in Skeletal Muscle Physiology and Pathophysiology
Lefevre, C., & Bindels, L. B. (2022) · Current Osteoporosis Reports · doi:10.1007/s11914-022-00752-9 · Cited by 43
Indoxyl Sulfate Contributes to Adipose Tissue Inflammation through the Activation of NADPH Oxidase
Tanaka, S., Watanabe, H., Nakano, T., Imafuku, T., Kato, H., Tokumaru, K., Arimura, N., Enoki, Y., Maeda, H., Tanaka, M., et al. (2020) · Toxins · doi:10.3390/toxins12080502 · Cited by 42
Self-citationAlcalde‐Estévez, E., Sosa, P., Asenjo‐Bueno, A., Plaza, P., Olmos, G., Naves‐Díaz, M., Rodríguez-Puyol, D., López‐Ongil, S., & Ruiz‐Torres, M. P. (2021) · Scientific Reports · doi:10.1038/s41598-020-79186-1 · Cited by 41
Yaşar, E., Tek, N. A., Tekbudak, M. Y., Depboylu, G. Y., Gülbahar, Ö., Uyar, G. Ö., Ural, Z., Çelik, Ö. M., & Erten, Y. (2022) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2022.01.011 · Cited by 41
The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction
da Cunha, R. S., Azevedo, C. A. B., Falconi, C. A., Fogaça-Ruiz, F., Liabeuf, S., Carneiro‐Ramos, M. S., & Stinghen, A. E. M. (2022) · Toxins · doi:10.3390/toxins14030177 · Cited by 40
Mechanisms of myostatin and activin A accumulation in chronic kidney disease
Bataille, S., Dou, L., Bartoli, M., Sallée, M., Aniort, J., Ferkak, B., Chermiti, R., McKay, N., Silva, N. D., Burtey, S., et al. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac136 · Cited by 40
Evidence for the Contribution of Gut Microbiota to Age-Related Anabolic Resistance
Watson, M. D., Cross, B. L., & Grosicki, G. J. (2021) · Nutrients · doi:10.3390/nu13020706 · Cited by 39
Gut microbiota disturbances and protein-energy wasting in chronic kidney disease: a narrative review
Martín-del-Campo, F., Avesani, C. M., Stenvinkel, P., Lindholm, B., Cueto-Manzano, A. M., & Cortés–Sanabria, L. (2023) · Journal of Nephrology · doi:10.1007/s40620-022-01560-1 · Cited by 39
Hung, K.-C., Yao, W.-C., Liu, Y.-L., Yang, H.-J., Liao, M.-T., Chong, K., Peng, C., & Lu, K. (2023) · Biomedicines · doi:10.3390/biomedicines11072076 · Cited by 39
Sarcopenia in chronic kidney disease: from bench to bedside
Kim, D. W., & Song, S. H. (2023) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2022.338 · Cited by 40
Hou, Y., Lu, C., Zheng, C., Chen, R., Lin, Y., Liu, W.-C., Yen, T., Chen, R., & Lu, K. (2019) · Nutrients · doi:10.3390/nu11010152 · Cited by 38
The Aryl Hydrocarbon Receptor in Chronic Kidney Disease: Friend or Foe?
Mo, Y., Lu, Z., Wang, L., Ji, C., Zou, C., & Liu, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.589752 · Cited by 38
Balestrieri, N. P., Palzkill, V. R., Pass, C. G., Tan, J., Salyers, Z. R., Moparthy, C., Murillo, A., Kim, K., Thome, T., Yang, Q., et al. (2023) · Circulation Research · doi:10.1161/circresaha.123.322875 · Cited by 38
Morella, I., Negro, M., Dossena, M., Brambilla, R., & D’Antona, G. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109718 · Cited by 37
The gut microbiome, chronic kidney disease, and sarcopenia
Zheng, G., Cao, J., Wang, X. H., He, W., & Wang, B. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01922-1 · Cited by 35
Indoxyl Sulfate Contributes to Uremic Sarcopenia by Inducing Apoptosis in Myoblasts
Rodrigues, G. G. C., Dellê, H., Brito, R. B. D. O., Cardoso, V. O., Fernandes, K. P. S., Mesquita‐Ferrari, R. A., da Cunha, R. S., Stinghen, A. E. M., Dalboni, M. A., & Barreto, F. C. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.12.020 · Cited by 35
Caldiroli, L., Armelloni, S., Eskander, A., Messa, P., Rizzo, V., Margiotta, E., Cesari, M., & Vettoretti, S. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111266 · Cited by 34
Gut-muscle axis and sepsis-induced myopathy: The potential role of gut microbiota
Liu, Y., Xu, L., Yang, Z., Wang, D., Li, T., Yang, F., Li, Z., Bai, X., & Wang, Y.-C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114837 · Cited by 34
Yin, Y., Liu, Y., Duan, G., Han, M., Gong, S., Yang, Z., Duan, Y., Guo, Q., Chen, Q., & Li, F. (2022) · Antioxidants · doi:10.3390/antiox11071373 · Cited by 33
Indoxyl Sulfate-Induced Macrophage Toxicity and Therapeutic Strategies in Uremic Atherosclerosis
Wakamatsu, T., Yamamoto, S., Yoshida, S., & Narita, I. (2024) · Toxins · doi:10.3390/toxins16060254 · Cited by 32
Cha, R., Kang, S. H., Han, M., An, W. S., Kim, S., & Kim, J. C. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12874 · Cited by 32
Higashihara, T., Nishi, H., Takemura, K., Watanabe, H., Maruyama, T., Inagi, R., Tanaka, T., & Nangaku, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-88438-7 · Cited by 33
Self-citationCharacterization of gut microbiota in mouse models of aging and sarcopenia
Lee, S. Y., Kim, J. H., Lee, D. Y., & Hur, S. J. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127462 · Cited by 30
Saadat, Y. R., Abbasi, A., Hejazian, S. S., Hekmatshoar, Y., Ardalan, M., Farnood, F., & Vahed, S. Z. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04057-8 · Cited by 29
Chang, S.-S., Chen, L., Huang, K., Huang, S.-W., Chang, C., Liao, K., Hu, E.-C., Chen, Y., Chen, Y., Hsu, P.-C., et al. (2023) · Food & Function · doi:10.1039/d3fo02766j · Cited by 28
Food, Nutrition, Physical Activity and Microbiota: Which Impact on Lung Cancer?
Nigro, E., Perrotta, F., Scialò, F., D’Agnano, V., Mallardo, M., Bianco, A., & Daniele, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18052399 · Cited by 27
Significance of serum Myostatin in hemodialysis patients
Esposito, P. B., Battaglia, Y., Porta, E. L., Grignano, M. A., Caramella, E., Avella, A., Peressini, S., Sessa, N., Albertini, R., Natali, G. D., et al. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1647-9 · Cited by 26
Skeletal Muscle Complications in Chronic Kidney Disease
Troutman, A. D., Arroyo, E., Lim, K. J., Moorthi, R. N., & Avin, K. G. (2022) · Current Osteoporosis Reports · doi:10.1007/s11914-022-00751-w · Cited by 25
Hsu, B., Wang, C., Lai, Y., Kuo, C., & Lin, Y. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13471 · Cited by 25
Bang, J., Jun, I., Lee, J.-B., Ko, Y., Kim, K. W., Jeong, J.-H., Kim, S., & Song, J. (2021) · Nutrients · doi:10.3390/nu13072212 · Cited by 24
Enoki, Y., Nagai, T., Hamamura, Y., Osa, S., Nakamura, H., Taguchi, K., Watanabe, H., Maruyama, T., & Matsumoto, K. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13159 · Cited by 23
Self-citationIndoxyl sulfate inhibits muscle cell differentiation via Myf6/MRF4 and MYH2 downregulation
Bataille, S., McKay, N., Koppe, L., Beau, A., Benoit, B., Bartoli, M., Silva, N. D., Poitevin, S., Aniort, J., Chermiti, R., et al. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfad123 · Cited by 23
Nishida, K., Watanabe, H., Miyahisa, M., Hiramoto, Y., Nosaki, H., Fujimura, R., Maeda, H., Otagiri, M., & Maruyama, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-75025-5 · Cited by 22
Self-citationBarisione, C., Verzola, D., Garibaldi, S., Ferrari, P. F., Garibotto, G., Ameri, P., Pane, B., Spinella, G., Pratesi, G., & Palombo, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189884 · Cited by 22
Price, S. R., & Wang, X. H. (2025) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.24.214 · Cited by 21
Osteosarcopenia: epidemiology, molecular mechanisms, and management
Yi, Y.-T., Zhao, H.-F., Wang, W., & Li, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1577758 · Cited by 21
Pharmacologic therapeutics in sarcopenia with chronic kidney disease
Cha, R. (2024) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.23.094 · Cited by 21
Creatinine generation rate can detect sarcopenia in patients with hemodialysis
Mae, Y., Takata, T., Yamada, K., Hamada, S., Yamamoto, M., Iyama, T., & Isomoto, H. (2021) · Clinical and Experimental Nephrology · doi:10.1007/s10157-021-02142-4 · Cited by 23
Baptista, I. L., Silvestre, J. G., Silva, W. J., Labeit, S., & Moriscot, A. S. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2614-z · Cited by 21
Thome, T., Vugman, N. A., Stone, L. E., Wimberly, K., Scali, S. T., & RYAN, T. E. (2024) · JCI Insight · doi:10.1172/jci.insight.178372 · Cited by 20
Lee, S. M., Han, M. Y., Kim, S. H., Cha, R., Kang, S. H., Kim, J. C., & An, W. S. (2022) · Toxins · doi:10.3390/toxins14100660 · Cited by 19
Zou, Y., Tang, X., Yang, S., Chen, Z., Liu, B., 周作琼, Peng, X., & Tang, C. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155972 · Cited by 19
Czaja-Stolc, S., Chatrenet, A., Potrykus, M., Ruszkowski, J., Torreggiani, M., Lichodziejewska–Niemierko, M., Dębska-Ślizień, A. M., Piccoli, G. B., & Małgorzewicz, S. (2024) · Nutrients · doi:10.3390/nu16152480 · Cited by 19
Tutakhail, A., Nazari, Q. A., Khabil, S., Gardier, A. M., & Coudoré, F. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.05.064 · Cited by 19
Oxidized Albumin: Evaluation of Oxidative Stress as a Marker for the Progression of Kidney Disease
Watanabe, H. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00586 · Cited by 18
Self-citationOrgan Crosstalk Contributes to Muscle Wasting in Chronic Kidney Disease
Wang, X. H., & Price, S. R. (2023) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2023.151409 · Cited by 18
Lin, Y., Liu, C., Lai, Y., Wang, C., Kuo, C., Liou, H., & Hsu, B. (2020) · Calcified Tissue International · doi:10.1007/s00223-020-00719-x · Cited by 18
Wesson, D. E., Mathur, V. S., & Tangri, N. (2022) · American Journal of Nephrology · doi:10.1159/000526679 · Cited by 17
Thome, T., Kim, K., Dong, G., & RYAN, T. E. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0143 · Cited by 17
Metadata
- Authors
- Enoki, Y., Watanabe, H., Arake, R., Sugimoto, R., Imafuku, T., Tominaga, Y., Ishima, Y., Kotani, S., Nakajima, M., Tanaka, M., Matsushita, K., Fukagawa, M., Otagiri, M., & Maruyama, T.
- Affiliations
- Kumamoto University (JP)
- Akebono Clinic (JP)
- Tokai University (JP)
- Sojo University (JP)
- Corresponding author
- Maruyama, Toru
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-08-23
- Volume
- 6
- Issue
- 1
- Pages
- 32084-32084
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4994088
- OpenAlex
- W2510093163
- Cited by
- 188
- References
- 43
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 20 · 2023: 30 · 2022: 24 · 2021: 24 · 2020: 19 · 2019: 18 · 2018: 9 · 2017: 7
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (16H05114, 15K15185, 15H04758, 16K08168, 16K15320, 25460190)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Keywords
- indoxyl sulfate, skeletal muscle atrophy, sarcopenia, chronic kidney disease, uremic toxins, oxidative stress, myostatin, atrogin-1, inflammatory cytokines, aryl hydrocarbon receptor, organic anion transporters, hemodialysis, muscle atrophy
- MeSH terms
- Animals, Antioxidants, Cell Division, Cell Line, Disease Models, Animal, Gene Expression Regulation, Indican, Male, Mice, Inbred C57BL, Muscle Proteins, Nephrectomy, Organ Size, Phosphorylation, Protein Processing, Post-Translational, Superoxides, Uremia, Weight Loss, Cytokines, Receptors, Aryl Hydrocarbon, Oxidative Stress, Muscle, Skeletal, Muscle Fibers, Skeletal, Organic Anion Transporters, Myoblasts, SKP Cullin F-Box Protein Ligases, Proto-Oncogene Proteins c-akt, Mice, Myostatin, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.